Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
HCA Healthcare stock has fallen sharply in the short term, yet over five years it is still in positive territory and currently screens as undervalued on several valuation checks. This sets up a clear tension between recent sentiment and longer term returns.
-
HCA Healthcare has returned 52.3% over the past five years, so long term holders remain ahead even after recent share price pressure.
-
Expectations around HCA Healthcare’s use of scale and AI tools to support care quality can help the investment case, while a rising load of uninsured patients and union related staffing pressures may weigh on profitability and investor confidence.
-
On Simply Wall St’s broader checks, HCA Healthcare screens as inexpensive across the board, with the company looking undervalued on 6 of 6 valuation measures.
For investors, the debate is whether the recent weakness in HCA Healthcare’s share price now offers a genuine discount or simply reflects the financial hit from a tougher payer mix and operating backdrop.
Find out why HCA Healthcare’s -1.5% return over the last year is lagging behind its peers.
Is HCA Healthcare Still Cheap on Earnings?
The P/E ratio is a useful way to see how much investors are paying for HCA Healthcare’s earnings today. HCA Healthcare trades on a P/E of about 11.9x, which is below both the broader Healthcare industry average of around 25.1x and the peer group average of roughly 15.0x.
On Simply Wall St’s fair multiple framework, HCA Healthcare’s P/E would be closer to 26.7x given its mix of growth, margins, size and risks. The current 11.9x therefore implies a wide discount to that reference point. Despite the recent cut to 2026 earnings guidance and concerns around a heavier uninsured patient load, the stock price still values HCA Healthcare at a level that screens as inexpensive relative to its earnings power on this model.
Overall, HCA Healthcare stock appears undervalued on the P/E multiple compared with both its industry and the fair ratio estimate.
See what the numbers say about this price — find out in our valuation breakdown.
The HCA Healthcare Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for HCA Healthcare sit on the company’s Community page and act as the bridge from the valuation puzzle above by explaining which paths for HCA Healthcare’s growth, margins and earnings would align with a meaningfully higher or lower stock price than today. Where a single ratio or model gives one number, these narratives describe the future that number is based on so you can watch how HCA Healthcare’s actual results compare over time.